GB201518170D0 - Colloidal particles for subcutaneous administration with intravenous administration of therapeutic agent - Google Patents

Colloidal particles for subcutaneous administration with intravenous administration of therapeutic agent

Info

Publication number
GB201518170D0
GB201518170D0 GBGB1518170.4A GB201518170A GB201518170D0 GB 201518170 D0 GB201518170 D0 GB 201518170D0 GB 201518170 A GB201518170 A GB 201518170A GB 201518170 D0 GB201518170 D0 GB 201518170D0
Authority
GB
United Kingdom
Prior art keywords
administration
therapeutic agent
colloidal particles
intravenous administration
subcutaneous administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1518170.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cantab Biopharmaceuticals Patents Ltd
Original Assignee
Cantab Biopharmaceuticals Patents Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cantab Biopharmaceuticals Patents Ltd filed Critical Cantab Biopharmaceuticals Patents Ltd
Priority to GBGB1518170.4A priority Critical patent/GB201518170D0/en
Publication of GB201518170D0 publication Critical patent/GB201518170D0/en
Priority to PCT/EP2016/074804 priority patent/WO2017064300A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
GBGB1518170.4A 2015-10-14 2015-10-14 Colloidal particles for subcutaneous administration with intravenous administration of therapeutic agent Ceased GB201518170D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1518170.4A GB201518170D0 (en) 2015-10-14 2015-10-14 Colloidal particles for subcutaneous administration with intravenous administration of therapeutic agent
PCT/EP2016/074804 WO2017064300A1 (en) 2015-10-14 2016-10-14 Colloidal particles for subcutaneous administration with intravenous administration of therapeutic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1518170.4A GB201518170D0 (en) 2015-10-14 2015-10-14 Colloidal particles for subcutaneous administration with intravenous administration of therapeutic agent

Publications (1)

Publication Number Publication Date
GB201518170D0 true GB201518170D0 (en) 2015-11-25

Family

ID=55131023

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1518170.4A Ceased GB201518170D0 (en) 2015-10-14 2015-10-14 Colloidal particles for subcutaneous administration with intravenous administration of therapeutic agent

Country Status (2)

Country Link
GB (1) GB201518170D0 (en)
WO (1) WO2017064300A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107982217B (en) * 2017-11-27 2019-08-23 徐州医科大学 A kind of tool targeting and radio therapy sensitization dual function lipid-polymer, preparation method and its application containing hydrophobic drug
GB202111759D0 (en) * 2021-08-17 2021-09-29 Cantab Biopharmaceuticals Patents Ltd Modified colloidal particles

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
AU7384994A (en) 1993-08-06 1995-02-28 Opperbas Holding B.V. A method for high loading of vesicles with biopolymeric substances
EP1079805B1 (en) 1998-04-27 2004-11-24 Opperbas Holding B.V. Pharmaceutical composition comprising factor viii and neutral liposomes
ATE317869T1 (en) 1999-07-14 2006-03-15 Alza Corp NEUTRAL LIPOPOLYMER AND LIPOSOMAL COMPOSITIONS THEREOF
US20030232075A1 (en) * 2002-05-06 2003-12-18 University Of Minnesota, A Minnesota Corporation Compositions for producing factor Xa
MXPA05010926A (en) 2003-04-15 2005-11-25 Opperbas Holding Bv Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles.
EP1898939A2 (en) * 2005-06-29 2008-03-19 The Research Foundation of State of University Of New York at Buffalo Compositions and methods for less immunogenic pr0tein-lip1d complexes
EP2437726B1 (en) 2009-06-03 2018-05-16 Sequessome Technology Holdings Limited Formulations for the treatment of deep tissue pain
NZ598906A (en) 2009-08-21 2014-08-29 Targeted Delivery Technologies Ltd Vesicular formulations
GB201007357D0 (en) 2010-04-30 2010-06-16 Leverton Licence Holdings Ltd Conjugated factor VIII
GB201007356D0 (en) 2010-04-30 2010-06-16 Leverton Licence Holdings Ltd Conjugated factor VIIa
PE20150226A1 (en) 2012-04-16 2015-02-14 Cantab Biopharmaceuticals Patent Ltd OPTIMIZED THERAPEUTIC AGENTS FOR SUBCUTANEOUS ADMINISTRATION

Also Published As

Publication number Publication date
WO2017064300A1 (en) 2017-04-20

Similar Documents

Publication Publication Date Title
IL263670A (en) Assemblies and methods for infusion pump system administration sets
EP2968739A4 (en) Infusion systems for the controlled delivery of therapeutic agents
IL262738B (en) Intravenous infusion set
IL247347A0 (en) Drug delivery systems and methods for treatment of bladder cancer with gemcitabine
EP3256133A4 (en) Intravenous infusion dosage form
IL275282A (en) Infusion pump systems and methods for administration sets
HK1256027A1 (en) Improved formulations of levosimendan for intravenous administration as infusion or injection and of infusion concentrate
HK1254855A1 (en) Intravenous administration of citrulline during surgery
ZA201703764B (en) Formulations of a pi3k/mtor-inhibitor for intravenous administration
GB201518170D0 (en) Colloidal particles for subcutaneous administration with intravenous administration of therapeutic agent
GB201518171D0 (en) Colloidal particles for topical administration with therapeutic agent
GB201412842D0 (en) Catheter for the delivery of therapeutic fluid
SG11201702061QA (en) Syringe infusion devices and systems for delivery of active agents
HK1244680A1 (en) Methods and compositions for the intravenous administration of fumarates for the treatment of neurological diseases
PL3804686T3 (en) Intravenous infusion dosage form for pemetrexed
GB201602754D0 (en) Extendible intravenous cannula
AU2014903720A0 (en) Syringe Infusion Devices and Systems for Delivery of Active Agents
AU2014903710A0 (en) Syringe infusion devices and systems for delivery of active agents
EP2978441A4 (en) Combination therapy for subcutaneous administration of glycopeptide antibiotics

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)
S30Z Assignments for licence or security reasons

Free format text: APPLICANT. CANTAB BIOPHARMACEUTICALS PATENTS LIMITED SECURITY INTEREST. FONDS RUSNANO CAPITAL S.A.